Pinsent Masons appoints prominent Life Sciences partner in London

02 Nov 2021 | 03:00 pm | 1 min. read

Multinational law firm Pinsent Masons has recruited partner Dr Gareth Morgan to its European Life Sciences team, further strengthening its technology, science and industry (TSI) sector capabilities.

Gareth, who joins from CMS, is a market-leading pharma patent and medicines regulatory specialist, with significant experience in all areas of contentious and non-contentious intellectual property (IP) law. He has acted in many landmark UK IP trials concerning patent entitlement, pharmaceutical and biotechnology patent validity and infringement, SPCs and the interpretation of IP licences.

Joining the firm’s London office, he brings with him a team of five lawyers who will all work closely with partner Catherine Drew to expand the firm’s medicine regulatory litigation offering.

With a PhD in molecular biology, Gareth is passionate about the life sciences sector and joins a full-service team where many hold relevant scientific qualifications and degrees, including in genetics, medicinal chemistry, human biology, and biochemistry.

Head of IP & Life Sciences Clare Tunstall said:

"The needs of our life sciences clients are continuously evolving, and we need to ensure that we can support them across all business-critical areas. The appointment of Gareth will significantly bolster our ability to service our international client base, particularly in respect of medicine regulatory and patent litigation work where we are seeing a growing demand across our European business".

Head of technology, science & industry Florian von Baum added:

"Gareth’s reputation precedes him; he is a market leading international practitioner with deep sector knowledge and will add invaluable strength to our team. His appointment bolsters key proficiencies across our multinational team.”

Gareth’s hire follows the recent appointment of life sciences partners Gina Bicknell in London and Machteld Hiemstra in Amsterdam.

Key Contacts

Clare Tunstall

Clare Tunstall

Partner, Head of IP & Life sciences

View Profile

Latest press releases

Show me all press releases

Pinsent Masons hires senior finance partner Nick Tostivin to lead its Finance team in London

Multinational law firm Pinsent Masons has appointed partner Nick Tostivin to join its rapidly expanding financial services team in London, where he will lead the Finance team.

Pinsent Masons recognised in China Business Law Journal's Deals of the Year 2023

Multinational law firm Pinsent Masons has been recognised in the Projects Deal of the Year category of the China Business Law Journal’s (CBLJ) Deals of the Year 2023 list for the firm’s work on the landmark NEOM Smart City Project in Saudi Arabia.

Pinsent Masons advises Bestinver Infra, FCR on acquisition of remaining shares in Irish toll road concession & operation companies

Pinsent Masons has advised Bestinver Infra, FCR on the acquisition of the remaining shares in N6 (Concession) Holdings Limited and N6 (Operations) Ltd, with Japanese co-investor Daiwa Energy & Infrastructure Co. Ltd.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Sandoz on acquisition of remaining shares in Rowex Joint Venture

Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.

Pinsent Masons appoints two partners and team of lawyers to launch TMT practice in Australia

Multinational law firm Pinsent Masons has appointed James Arnott and Veronica Scott and a team of lawyers to launch the firm’s Technology, Media and Telecommunications (TMT) practice in Australia.

Pinsent Masons advises on strategic investment in cloud and digital transformation services provider Kerv Group

Multinational law firm Pinsent Masons has advised Kerv Group on the strategic investment by Bridgepoint Development Capital (BDC).

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.